Clinical Trials Directory

Trials / Terminated

TerminatedNCT02180282

Impact of the M22-IPL Acne Filter on Acne Vulgaris

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Lumenis Be Ltd. · Industry
Sex
All
Age
15 Years – 45 Years
Healthy volunteers
Accepted

Summary

Up to 20 healthy subjects age 15-45 years old ,Skin Phototype I-V,Study will be conducted in 1 site. Primary objectives is to evaluate the efficacy of IPL acne filter treatment for improvement of acne vulgaris as assessed by lesion count. .

Conditions

Interventions

TypeNameDescription
DEVICEM22-IPLThe M22 is an advanced computer-controlled light emission system that incorporates several different light modules. The IPL hand piece operates at a spectrum of 400-1200nm with 7 different filters that can be easily inserted to the hand piece to treat different conditions. The IPL hand piece also includes 2 different sapphire cooled light guides of 8x15mm and 15x35mm. The cut-off filter that will be used for this evaluation is the Acne Filter that cuts off all light with the wavelength of 400-600 and 800-1200nm.

Timeline

Start date
2014-07-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2014-07-02
Last updated
2017-01-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02180282. Inclusion in this directory is not an endorsement.

Impact of the M22-IPL Acne Filter on Acne Vulgaris (NCT02180282) · Clinical Trials Directory